日本降压药依普利酮效果好吗
Are Japanese antihypertensive drugs effective? Eplerenone is a new generation of selective aldosterone antagonist developed by Pfizer/Pharmacia. Indications: used for essential hypertension and heart failure after myocardial infarction. For severe hypertension that cannot be controlled by a combination of multiple antihypertensive drugs, the addition of eplerenone can significantly reduce blood pressure, especially the decrease in systolic blood pressure is more significant. Combined treatment with angiotensin-converting enzyme inhibitors (ACEI) and beta-blockers can improve patients' quality of life and reduce mortality in severe heart failure and myocardial infarction.
Eplerenone is very effective in treating patients with hypertension, and it has a positive effect whether it is used alone or in combination with antihypertensive drugs. Eplerenone is administered orally, with an initial dose of 50 mg once a day and a maintenance dose of 50 mg once or twice a day. The maximum dose is 100 mg/day and patients should not overdose. During the period of treatment with this drug, patients should not increase or decrease the dose of the drug without authorization. Only correct use of the drug will help the condition.
Taking eplerenone for treatment will also produce certain side effects or adverse reactions, including: hyperkalemia/hypertriglyceridemia/dizziness/fatigue/hyponatremia/proteinuria/hypercholesterolemia/abdominal pain/increased serum creatinine/cough/angioedema/increased liver enzymes/rash, etc. Therefore, patients must go to the hospital for detailed examination before receiving this drug for treatment, and use the drug strictly according to the doctor's diagnosis and treatment recommendations.
The above is the introduction about (eplerenone), I hope it can help everyone. If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.
Recommended related hot articles: /newsDetail/79932.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)